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Lung entrapmentAbstract Pleural manometry is a valuable tool to determine lung expansibility and helps to avoid
unsafe pressure changes during thoracentesis.
Study design: Cross-sectional descriptive study.
Aim of the work: To measure the pleural pressure during thoracocentesis in patients with pleural
effusion and the value of their measurement in both diagnostic and therapeutic decisions.
Patients and methods: Forty-four patients with pleural effusion were included. Thoracocentesis
was performed for all patients. End-expiratory pleural pressure values were recorded after the with-
drawal of 5 ml of fluid (initial pleural pressure), after the removal of every 500 ml for the first liter
then after the withdrawal of every 250 ml for the second liter, and every 100 ml thereafter until the
procedure completed. The last recorded pressure was used as the closing pressure. Comparisons
were done according to the etiology and character of the effusion (transudate or exudate). The pres-
sure/volume curves were done and studied.
Results: Twenty out of 34 patients with exudative pleural effusion having a pleural space elas-
tance >14.5 cm H2O/L were identified. These patients had a diagnosis of malignant effusion either
primary or secondary (14/20 patients), or inflammatory causes (6/20 patients). All the 10 patients
with transudative effusion had an elastance <14.5 cm H2O/L. The study revealed a statistically sig-
nificant decrease in closing pressure in the symptomatic group when compared to non-symptomatic
group (p value = 0.022), none of our patients (including symptomatic patients) had exceeded the
proposed cutoff value for unsafe pleural pressures (20 cm H2O).
Conclusion: Pleural manometry is proved a useful tool to differentiate freely expandable lungs
from lungs with entrapment. It is proved as a useful guide as to when to terminate thoracentesis
in large volume thoracentesis.
 2016 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/)., Egypt.
Figure 1 A schematic diagram illustrating the complete pleural
manometer setup.
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Pleural effusion is diagnosed in approximately 1.5 million
patients each year in the United States, making therapeutic
thoracocentesis one of the most commonly performed medical
procedures [1].
Measurement of pleural liquid and surface pressure in a
normal pleural space is technically challenging because the
normal pleural space is only approximately 20 lm thick, and
the insertion of any device into the pleural space will create
deformation that was not present before the insertion of the
device [2].
Pleural manometry provides data to enhance our under-
standing of the underlying pleural pathophysiology when an
effusion is present and aids the physician in both diagnostic
and therapeutic decisions [3], and can help him to avoid unsafe
pressure changes during thoracentesis and to avoid re-
expansion pulmonary edema.
Clinically, obtaining information about the elastic charac-
teristics of the pleural space is the objective of pleural space
manometry [4].
Pleural elastance (PE) has been defined as the change
observed in pleural pressure divided by the amount of fluid
removed. A normal pleural elastance is estimated to be
< 14.5 cm H2O/L [5].
Aim of the work
The study was designed as a cross-sectional descriptive study
aiming to measure the pleural pressure during thoracocentesis
in patients with pleural effusion and the value of their mea-
surement in both diagnostic and therapeutic decisions.
Patients and methods
The study was carried out at Kasr Al-Aini hospital, Chest
Department. A total of 44 patients with pleural effusion were
included into the study. The following were excluded from the
study: patients with very small amounts of pleural effusion,
patients on mechanical ventilation, patients using anticoagu-
lant therapy, patients refusing to be subjected to
thoracocentesis.
The patient was sitting with his arms on the back of the
chair, causing the intercostal spaces to be extended and facili-
tates access. The skin was cleaned with betadine antiseptic
solution. Pleural aspiration should take place in a clean area
using full aseptic techniques. 5–10 cc Lidocaine 2% was given
as local anesthetic in the site of puncture. 1 cc atropine was
injected intramuscularly. Site of insertion:-into the lowest zone
of the effusion determined either by auscultation or by sono-
graphic guidance. At the upper border of the lower rib.
Thoracocentesis was performed for all patients with the use
of wide bore catheter (16 guage) and IV sets.
As shown in Fig. 1, the measurement of pleural pressure
was done by a simple water column manometer as that
designed for measuring CVP. The water manometer consists
of two lengths of intravenous tubing connected through a three
way valve to a wide bore catheter inserted in the pleural space.
The tubing from the thoracocentesis catheter to the measuring
scale extends 40–50 cm below the level of the catheter insertioninto the chest similar to a U-shaped water manometer .The
system (IV tubing) is purged of air with normal saline. Zero
value was set at the thoracic puncture level.
After pressure recording the water manometer described
above was removed. The catheter was connected to a fluid
drainage bag through IV tubing for drainage. End-expiratory
pleural pressure values were recorded after the withdrawal of
5 ml of fluid (initial pleural pressure), after the removal of
every 500 ml for the first liter then after the withdrawal of
every 250 ml for the second liter, and every 100 ml thereafter
until the procedure completed.
Thoracocentesis was discontinued when no more fluid
could be obtained; the patient developed symptoms related
to the removal of fluid (i.e., chest pain, cough or chest tight-
ness), or pleural pressure become 20 cm H2O or lower.
The last recorded pressure was used as the closing pressure.
Initial and further pleural pressures, volume of fluid
removed were measured in all pleural effusion patients, and
comparisons were done according to the etiology and charac-
ter of the effusion (transudate or exudate).The pressure/vol-
ume curves were done and studied.
Statistical analysis
Gathered data were processed using SPSS version 15 (SPSS
Inc., Chicago, IL, USA). Quantitative data were expressed as
mean ± SD while qualitative data were expressed as numbers
and percentages (%). Student t test was used to test signifi-
cance of difference for quantitative variables and Chi Square
was used to test significance of difference for qualitative vari-
ables. A probability value of p-value <0.05 was considered
statistically significant.
Results
In the current study, 44 patients with pleural effusion were
enrolled. Mean age of the studied patients was 50.8 with range
from 17 to 70 years old. More than half of the studied patients
were females (52.3%). About 45.5% of the pleural effusion
patients were smokers. The most common chronic medical
conditions were hypertension and DM (13.6%). Regarding
co morbidities 11.4% of the studied patients had history of
Table 1 Effusion type and etiology among the studied
patients.
Type Etiology Number Percentage
(%)
Exudative 34 77.3
Tuberculosis 5 11.4
Parapneumonic 8 18.2
Empyema 1 2.3
Bronchogenic
carcinoma
12 27.3
Mesothelioma 5 11.4
Metastatic carcinoma 3 6.7
Transudative 10 22.7
CHF 3 6.8
Hepatic hydrothorax 5 11.4
Renal impairment 2 4.5
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Figure 2 Pleural elastance curve of a case with metastatic
adenocarcinoma. The curve represents an initial normal elastance
that becomes abnormally high as more fluid is removed (‘‘en-
trapped lung”).
Figure 3 Pleural elastance curve of a case with hepatic
hydrothorax. The curve represents normal pleural elastance.
Pleural manometry in pleural effusion 417chronic liver disease, 4.5% had history of chronic renal disease
while cardiac disease was reported among 6.8% of patients.
Radiological examination revealed that most of the patients
(59%) had right-sided pleural effusion. Most of the patients
had massive pleural effusion as appeared by occupied zones
on Chest X-ray (53.9%), 34.6% of patients had moderate effu-
sion, 11.5% of patients had mild effusion. According to bio-
chemical analysis 77.3% had exudative pleural effusion while
22.7% had transudative pleural effusion (Table 1).
Thoracentesis was performed to the pleural effusion
patients, the procedures stopped in 6.8% of patients due to
cough or chest discomfort, 29.5% of them stopped for perfor-
mance of subsequent thoracoscopy procedure, and 63.6% had
no more aspirated fluid. Mean pleural fluid volume removed
during the procedure was 1.222 ± 0.408 L (range: 0.25–2.35).
In our study 20 out of 34 patients with exudative pleural
effusion having a pleural space elastance >14.5 cm H2O/L
were identified. These patients had a diagnosis of malignant
effusion either primary or secondary (14/20 patients), or
inflammatory causes (6/20 patients) (Fig. 2).
All the 10 patients with transudative effusion had an elas-
tance <14.5 cm H2O/L (Fig. 3).
There was a statistically significant increase in baseline
pleural pressure, and pleural elastance in exudative pleural
effusion when compared to transudative effusion. Also, therewas a statistically significant increase in pleural elastance in
malignant when compared to benign pleural effusion (Tables
2 and 3).
Patients who developed symptoms during the procedure
i.e., cough, chest discomfort and chest pain were compared
to patients that did not develop these symptoms as regards ini-
tial pleural pressure, closing pressure, and elastance (Table 4).
Discussion
The monitoring of pleural pressure (Ppl) during thoracocente-
sis not only provides a better understanding of the real-time
physiology of the pleural space, but also helps to prevent
pressure-related complications such as reexpansion pulmonary
edema [7]to predict improvement in FVC, [8] and to predict the
success of pleurodesis [9].
In the current study, there was a statistically significant
increase in the initial pleural pressure, and pleural elastance
in exudative pleural effusion when compared to transudative
effusion. Also, there was a statistically significant increase in
pleural elastance in malignant when compared to benign pleu-
ral effusion.
In 1980, Light and colleagues measured pleural elastance in
52 patients during thoracocentesis and described the following
three distinct pleural elastance curves: (1) removal of a large
amounts of fluid with minimal change in pressure (normal
pleural elastance, as can be seen in patients with hepatic
hydrothorax or congestive heart failure); (2) a relatively nor-
mal initial curve followed by a sharp drop in pressure (lung
entrapment); and (3) a negative initial pressure with a rapid
drop in pressure (trapped lung) [10] (Fig. 4).
In the present study all the 10 patients with transudative
effusion had a normal pleural elastance (i.e., <14.5 cm H2O/
L).The pressure volume curve was monophasic and flat (see
Fig. 2). This signifies that the lung is freely expandable.
There were 20 out of 34 patients with exudative pleural
effusion that had higher than normal pleural elastance (i.e.,
>14.5 cm H2O/L). These patients had a diagnosis of malig-
nant effusion either primary or secondary (14/20 patients), or
inflammatory causes (6/20 patients) (see Fig. 3). This signifies
that inflammatory and malignant infiltrates on the visceral
pleura prevented the lung from free expansion and there was
evidence of lung entrapment.
None of the studied patients showed rapid drop in pleural
pressure i.e., trapped lung.
Table 2 Comparison between exudative and transudative effusion.
Exudate (n= 34) Transudate (n= 10) p value
Total aspirate 1133.82 ± 474.45
(250:2350)
1350 ± 241.52
(1000:1500)
0.174
Initial pleural pressure 15.20 ± 8.68
(1:33)
8.6 ± 3.56
(2:13)
0.024
Closing pressure 5.01 ± 5.16
(14:13)
2.4 ± 2.31
(6:2)
0.129
Elastance 16.68 ± 6.66
(5:28.6)
8.16 ± 2.29
(3.43:10.67)
0.0003
Values are shown as: mean ± SD, range (Minimum:Maximum), Sig: p value < 0.05.
Modified Light’s criteria were followed to discriminate between transudate and exudate [6].
Table 3 Comparison between malignant and benign effusion.
Malignant
(n= 20)
Benign
(n= 24)
p
value
Total aspirate 1165 ± 558.68
(250:2350)
1197.91
± 321.16
(1000:1500)
0.808
Initial pleural
pressure
15.1 ± 7.43
(2:30)
12.54 ± 8.89
(1:33)
0.312
Closing pressure 5.75 ± 6.07
(14:13)
3.31 ± 3.06
(10:2)
0.133
Elastance 17.80 ± 6.12
(5:28.6)
12.20 ± 6.66
(3.43:27)
0.041
Mean ± SD, range (Minimum:Maximum), Sig: p value <0.05.
Table 4 Comparison between symptomatic and non-symp-
tomatic patients.
No symptoms
(n= 35)
With symptoms#
(n= 9)
p
value
Initial PP 12.42 ± 7.78
(1:32)
18.66 ± 8.67
(6:33)
0.042
Closing
pressure
3.6 ± 4.44
(12:13)
7.61 ± 4.93
(14:0)
0.022
Elastance 13.48 ± 6.28
(5:27)
19.63 ± 7.60
(3.43:28.6)
0.016
Mean ± SD, range (Minimum:Maximum), Sig: p value <0.05.
# Symptoms included cough and chest discomfort.
Figure 4 Pleural elastance curves. The slopes of the different
curves represent pleural space elastance. Curve 1 represents a
normal pleural elastance and curve 3 represents abnormally high
pleural elastance (‘‘trapped lung”), whereas curve 2 represents an
initial normal elastance that becomes abnormally high as more
fluid is removed (‘‘entrapped lung”) [11].
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pressure in the evaluation of pleural effusions, and they con-
cluded that pleural manometry provides data to enhance our
understanding of the underlying pleural pathophysiology when
an effusion is present and aids the physician in both diagnostic
and therapeutic decisions. The measurement of pleural pres-
sure helps to detect lung entrapment, allows for the safe
removal of large effusions, and is a useful tool to select appro-
priate patients with malignant pleural effusions for pleurode-
sis. [12]
Most studies of pleural manometry have stopped thoraco-
centesis for pleural pressure values lower than 20 cm H2O
or for symptoms such as cough or chest pain. The value of
20 cm H2O was arbitrarily chosen by [10] based on prior ani-
mal studies [13] demonstrating minimal pulmonary edema
with Ppl values of 20 mmHg (approximately 27 cm H2O)but significant pulmonary edema with pressures of 40 mmHg
(approximately 54 cm H2O).
Patients who developed symptoms during the procedure
i.e., cough, chest discomfort, chest pain were compared to
patients that did not develop these symptoms as regards initial
pleural pressure, closing pressure and elastance.
The study revealed a statistically significant decrease in
closing pressure in the symptomatic group when compared
to non-symptomatic group (p value = 0.022).
Although in our study symptomatic patients had signifi-
cantly less closing pleural pressure and higher elastance than
asymptomatic ones, none of our patients had exceeded the
proposed cutoff value for unsafe pleural pressures
(20 cm H2O).
This was on concordance with Feller-Kopman et al. who
investigated the relationship of patients’ symptoms during
therapeutic thoracocentesis to pleural pressure (Ppl). The clos-
ing pressures were significantly lower in the group of patients
who experienced chest discomfort compared to patients who
were asymptomatic [3].
They also found that only 22% of patients in whom chest
discomfort developed, and 8.6% of patients in whom symp-
toms did not develop, had potentially dangerous Ppl values
(i.e., lower than 20 cm H2O).
Pleural manometry in pleural effusion 419At this point one should conclude that development of
symptoms alone is not an indication to terminate the proce-
dure and pleural pressure measurement at this time would be
of great value to take the decision of termination.
Conclusion
Pleural manometry is proved a useful tool to differentiate
freely expandable lungs from lungs with entrapment. It is
proved as a useful guide as to when to terminate thoracentesis
in large volume thoracentesis.
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